Immunotherapy and Policy. How can the FDA evolve to help advance and support novel approaches to medicine? How does the field of immune-driven diagnostics serve as a case in point for the need for evolution in existing regulatory frameworks?


Special guests:

Meghan Gutierrez

Chief Executive Officer

Lymphoma Research Foundation


Leo David Wang, M.D., Ph.D.

Assistant Professor, Department of Immuno-Oncology

Assistant Professor, Department of Pediatrics

City Of Hope


This series is brought to you ad-free by Adaptive Biotechnologies